Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence

Current Allergy and Asthma Reports · Published 2026-04-16 · DOI 10.1007/s11882-026-01271-8

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11882-026-01271-8

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• COPD Stability and Asthma Remission: Different Words for the Same Therapeutic Ambition? · Biomedicines · 2026 · Cites or is cited by this article
• A Review of Adenosine Deaminase 2 (ADA2) as a Biomarker of Monocyte/Macrophage Activation · Current Allergy and Asthma Reports · 2026 · Same journal
• Impact of Pesticide Exposure on Asthma and Allergic Airway Disease · Current Allergy and Asthma Reports · 2026 · Same journal
• Occupational Allergy to Rat and Mouse in Research Laboratories · Current Allergy and Asthma Reports · 2026 · Same journal
• The Modern Environment and Childhood Asthma: The Role of Air Pollution and Heavy Metal Exposure · Current Allergy and Asthma Reports · 2026 · Same journal
• 4-Week Maintenance ICS-Formoterol versus ICS in Adults Newly Diagnosed Mild Asthma: Effects on Symptoms, Lung Function, and Inflammation · Current Allergy and Asthma Reports · 2025 · Same journal
• Autoallergy and what the Allergist Needs to know · Current Allergy and Asthma Reports · 2025 · Same journal
• Cross-Talk between Neurons and Immune Cells in Pruritus: from Mechanisms To Medicines · Current Allergy and Asthma Reports · 2026 · Same journal
• Emerging Therapeutic Strategies in Asthma: Advances in Treatment, Drug Delivery, Drug Adherence, and Disease Management · Current Allergy and Asthma Reports · 2026 · Same journal
• Targeting Type 2 and Non-type 2 Asthma: Emerging Biologics and Personalized Strategies · Current Allergy and Asthma Reports · 2026 · Same journal